Purpose To investigate the quantitative vascular or structural differences in the foveal section of the eyes in ROP children and healthy children using optical coherence tomography angiography (OCTA).Methods This cross-sectional observational comparative study consisted of 75 eyes (44 subjects). Subjects were divided into 4 groups based on the diagnosis or treatment: diagnosed with ROP and treated by intravitreal injection of Conbercept, or Ranibizumab, lesions spontaneously regressed, and healthy age-matched term-born children. Central foveal thickness (CFT), foveal avascular zone (FAZ), superficial/deep capillary plexus (SCP/DCP), and choroidal vessel density (VD) at the foveal section were collected by spectral-domain OCT and OCTA. Correlations between foveal microvasculature, preterm status and visual acuity were also evaluated.Results There were significant differences between the four groups in the FAZ area, CFT, VD-SCP (whole-image), and VD-SCP (parafoveal). The FAZ area of ROP children was significantly smaller than that in age-matched term-born healthy children (p=0.009). The CFT of group Conbercept was considerably lower than that of the group Ranibizumab (p=0.044). The FAZ area showed a positive correlation with choroid VD (p=0.012) and a negative correlation with CFT, VD-SCP (foveal), and VD-DCP (foveal)(p<0.001, p<0.001, p=0.001), whilst the CFT was positively correlated with VD-SCP (foveal) and VD-DCP (foveal)(p=0.003, p=0.001).Conclusion ROP children possess a smaller FAZ area, of which no significant difference is noted when comparing different anti-VEGF agents employed. Anti-VEGF treatment could reduce the CFT, and Conbercept had a better performance than Ranibizumab. Correlation between the microvascular anomalies and central foveal thickness also exists.